1. Home
  2. AFCG vs PMVP Comparison

AFCG vs PMVP Comparison

Compare AFCG & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AFC Gamma Inc.

AFCG

AFC Gamma Inc.

HOLD

Current Price

$2.75

Market Cap

61.4M

Sector

Real Estate

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.19

Market Cap

66.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFCG
PMVP
Founded
2020
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
66.1M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
AFCG
PMVP
Price
$2.75
$1.19
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
83.0K
403.6K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
6.94%
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$24,563,601.00
N/A
Revenue This Year
$1,334.03
N/A
Revenue Next Year
$17.33
N/A
P/E Ratio
$5.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.06
$1.02
52 Week High
$5.10
$1.88

Technical Indicators

Market Signals
Indicator
AFCG
PMVP
Relative Strength Index (RSI) 43.46 47.44
Support Level $2.49 $1.05
Resistance Level $2.78 $1.26
Average True Range (ATR) 0.12 0.08
MACD 0.03 -0.01
Stochastic Oscillator 50.00 39.44

Price Performance

Historical Comparison
AFCG
PMVP

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: